1529-0131a/asset/cover.gif?v=1&s=4b71f39689e424fbb0e6725b1c033cc646a4272b "Arthritis Care & Research")
Direct Link:
2151-4658/asset/olbannerleft.gif?v=1&s=75d1dd4933b4687fdb365bb32190b0a4ef453ee7)
2151-4658/asset/olbannerright.gif?v=1&s=a36ba6af41bd9af370864f6461a516746a709d31)
Original Article
You have full text access to this OnlineOpen article
High rate of renal relapse in 71 patients with Wegener's granulomatosis under maintenance of remission with low-dose methotrexate
Article first published online: 5 JUN 2002
DOI: 10.1002/art.10459
Copyright © 2002 by the American College of Rheumatology
Additional Information
How to Cite
Reinhold-Keller, E., Fink, C. O. E., Herlyn, K., Gross, W. L. and de Groot, K. (2002), High rate of renal relapse in 71 patients with Wegener's granulomatosis under maintenance of remission with low-dose methotrexate. Arthritis & Rheumatism, 47: 326–332. doi: 10.1002/art.10459
Publication History
- Issue published online: 5 JUN 2002
- Article first published online: 5 JUN 2002
- Manuscript Accepted: 1 NOV 2001
- Manuscript Received: 3 OCT 2001
- Abstract
- Article
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, , , , , , , , Improved outcome in 445 patients with Wegener's granulomatosis in a German vasculitis center over four decades, Arthritis & Rheumatism, 2011, 63, 1
- 2, , , Vasculitides Throughout History and Their Clinical Treatment Today, Current Rheumatology Reports, 2011, 13, 6, 465
- 3
- 4, ANCA Associated Vasculitis, The Journal of the Korean Rheumatism Association, 2010, 17, 2, 108
- 5, , , , Effects of duration of glucocorticoid therapy on relapse rate in antineutrophil cytoplasmic antibody–associated vasculitis: A meta-analysis, Arthritis Care & Research, 2010, 62, 8Direct Link:
- 6, , , , , Predictors at diagnosis of a first Wegener's granulomatosis relapse after obtaining complete remission, Rheumatology, 2010, 49, 11, 2181
- 7, , Tratamiento de las vasculitis sistémicas asociadas a ANCA, ReumatologÃa ClÃnica, 2010, 6, 3, 161
- 8, , Treatment of ANCA-associated systemic vasculitis, ReumatologÃa ClÃnica (English Edition), 2010, 6, 3, 161
- 9
- 10
- 11, , ANCA-associated vasculitides: Pathogenetic aspects and current evidence-based therapy, Journal of Autoimmunity, 2009, 32, 3-4, 163
- 12, , Risk factors for treatment failures in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis, Current Rheumatology Reports, 2009, 11, 6, 416
- 13, , Role and place of methotrexate in vasculitis management, International Journal of Clinical Rheumatology, 2009, 4, 6, 697
- 14, , Wegener-Granulomatose und mikroskopische Polyangiitis, Zeitschrift für Rheumatologie, 2009, 68, 1, 49
- 15
- 16, , , , , Induction and maintenance therapy in ANCA-associated systemic vasculitis, Nephrology, 2008, 13,Direct Link:
- 17, , , , , , , , , , Intravenous immunoglobulins for relapses of systemic vasculitides associated with antineutrophil cytoplasmic autoantibodies: Results of a multicenter, prospective, open-label study of twenty-two patients, Arthritis & Rheumatism, 2008, 58, 1Direct Link:
- 18, , , , , , , Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody–associated small-vessel vasculitis: Comparison of two independent cohorts, Arthritis & Rheumatism, 2008, 58, 9Direct Link:
- 19
- 20, , , Biological therapies: new treatment options for ANCA-associated vasculitis?, Expert Opinion on Biological Therapy, 2007, 7, 4, 521
- 21, , , , Ocular manifestations of Wegener’s granulomatosis, Expert Review of Ophthalmology, 2007, 2, 1, 91
- 22, , Respiratory System Involvement??in Antineutrophil??Cytoplasmic-Associated Systemic Vasculitides, Drugs in R & D, 2007, 8, 1, 25
- 23, Small-vessel vasculitis: Therapeutic management, Current Rheumatology Reports, 2007, 9, 4, 328
- 24, Vasculitis in the Geriatric Population, Rheumatic Disease Clinics of North America, 2007, 33, 1, 177
- 25, , When should patients with ANCA-associated vasculitis be switched from induction to maintenance therapy?, Nature Clinical Practice Nephrology, 2007, 3, 5, 236
- 26
- 27, , , Advances in the therapy of Wegenerʼs granulomatosis, Current Opinion in Rheumatology, 2006, 18, 1, 25
- 28, , Advances in the Treatment of Small Vessel Vasculitis, Rheumatic Disease Clinics of North America, 2006, 32, 1, 157
- 29, , Therapeutics of Wegener's granulomatosis, Nature Clinical Practice Rheumatology, 2006, 2, 4, 192
- 30, , , , , , Wegener Granulomatosis: A Case Report and Update, Southern Medical Journal, 2006, 99, 9, 977
- 31, Wegener-Granulomatose im Kindes- und Jugendalter, Monatsschrift Kinderheilkunde, 2006, 154, 9, 880
- 32, , , Wegener’s Granulomatosis: Ophthalmic Manifestations and Management, Seminars in Arthritis and Rheumatism, 2006, 35, 5, 284
- 33, , Difficult to diagnose manifestations of vasculitis: Does an interdisciplinary approach help?, Best Practice & Research Clinical Rheumatology, 2005, 19, 2, 243
- 34, How can relapses be detected and prevented in primary systemic small-vessel vasculitides?, Best Practice & Research Clinical Rheumatology, 2005, 19, 2, 307
- 35, How to induce remission in primary systemic vasculitis, Best Practice & Research Clinical Rheumatology, 2005, 19, 2, 293
- 36
- 37, Methotrexate for Wegener's granulomatosis: What is the evidence?, Arthritis & Rheumatism, 2005, 52, 8Direct Link:
- 38, , , , , , , , , Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody–associated vasculitis, Arthritis & Rheumatism, 2005, 52, 8Direct Link:
- 39
- 40
- 41, , , , Positive classic antineutrophil cytoplasmic antibody (C-ANCA) titer at switch to azathioprine therapy associated with relapse in proteinase 3–related vasculitis, Arthritis Care & Research, 2004, 51, 2Direct Link:
- 42, , , Pulmonary Effects of Low-Dose Methotrexate Therapy, Clinical Pulmonary Medicine, 2004, 11, 5, 307
- 43, , Recent progress in the pharmacotherapy of Churg-Strauss syndrome, Expert Opinion on Pharmacotherapy, 2004, 5, 1, 25
- 44, , , Renal vasculitis--an update in 2004, Nephrology Dialysis Transplantation, 2004, 19, 8, 1964
- 45
- 46, , , Head and neck manifestations of Wegener's granulomatosis, Otolaryngologic Clinics of North America, 2003, 36, 4, 685
- 47, , New insights into the immunopathogenesis and treatment of small vessel vasculitis of the kidney, Current Opinion in Nephrology and Hypertension, 2003, 12, 3, 267
- 48, , , , , Serial ANCA titers: Useful tool for prevention of relapses in ANCA-associated vasculitis, Kidney International, 2003, 63, 3, 1079
- 49, , , , Use of a cyclophosphamide-induction methotrexate-maintenance regimen for the treatment of Wegener’s granulomatosis: extended follow-up and rate of relapse, The American Journal of Medicine, 2003, 114, 6, 463